|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 16819325.8 (espacenet) (Federated) (European Patent Register), 20161227 | Patent/reg. no. and date | DK/EP 3377064, 20190626 | Publication date | 20180926 | Priority no. and date | US 201662276237 P, 20160108, US 201662408921 P, 20161017 | EP pub. no. and date |
EP 3377064 20180926 | Effective date | | Applicant/owner | NeRRe Therapeutics Limited, Stevenage Bioscience Catalyst Office F25 Incubator Building Gunnels Wood Road
Stevenage, Hertfordshire SG1 2FX, GB | Applicant ref. no. | P178922.DK.01/KERRS/LJUNGBERGR | Inventor | TROWER, Mike, C/O NeRRe Therapeutics Limited Stevenage Bioscience Catalyst Incubator Building Gunnels Wood Road
Stevenage Hertfordshire SG1 2FX, GB | Representative | MURGITROYD & COMPANY, Mannerheimvägen 12B, 5tr
FI-00100 Helsingfors, FI | Opponent | | IPC Class | A61K 31/4985 (2006.01) , A61K 9/20 (2006.01) , A61P 11/14 (2006.01) | Title | Orvepitant til behandling af kronisk hoste | Int. application no. | EP2016082698 | Int. publication no. | WO2017118584 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |